Daniel Berrebi, a 2017 WVU Cancer Institute summer research fellow, won first place in the cancer category of the student poster session at this year’s Southeast Regional IDeA Conference in Morgantown. He was selected for his research titled Inhibition of CCL5 and Nodal by Adipose-derived Stem Cells in the Breast Tumor Microenvironment. In his work at the Cancer Institute under the mentorship of Linda Vona-Davis, PhD, Berrebi used 3D matrix models to study the role of stem cells in contributing to the spread of breast cancer.
The Southeast Regional IDeA Conference is a biennial meeting that connects biomedical research from across the seven states/territories in the southeast IDeA Region to discuss best practices, concepts, and ideas to further research throughout the region.
“This conference was a great opportunity to network with colleagues from across the region and discuss my research,” Berrebi said. “I am incredibly honored that my work was recognized with this award.”
Berrebi is a senior at WVU and is majoring in biology. He plans to go to medical school, then complete a surgical residency and continue investigative research as a physician. He is the son of Denise and Albert Berrebi of Morgantown.
WVU Cancer Institute's Cancer Prevention and Control, in collaboration with the West Virginia Cancer Registry, has released the 2018 Cancer Burden Report. The report provides updated statewide, age-adjusted incidence rates and counts for cancer diagnosed among West Virginia residents from 2011 to 2015.
West Virginia University's Cancer Institute is well-known for its treatment and innovation. Leading the institute is Dr. Richard Goldberg, who has not only established himself as a transformative leader but also a potent researcher and educator.
Brian Boone, M.D., surgical oncologist in the WVU Medicine Department of Surgery and WVU Cancer Institute, performed the state’s first hyperthermic intraperitoneal chemotherapy (HIPEC) infusion. This treatment delivers heated, sterilized chemotherapy to the abdomen as a treatment for cancer that has spread to the lining of the abdominal cavity, or peritoneum.